RT

Robert Tepper

Partner at Third Rock Ventures

Boston, Massachusetts

Overview 

Robert Tepper is a Partner at Third Rock Ventures, where he has successfully invested in companies like Casma Therapeutics and Bluebird Bio. With a background as President of Research & Development at Millennium Pharmaceuticals and serving as a Council Member at NCATS, he brings a wealth of experience in the pharmaceutical and biotech sectors to his current role.

Work Experience 

TR

Third Rock Ventures

  • Partner

    2007 - Current

NCATS

  • Council Member

    2012 - 2017

Neon Therapueutics

  • Interim CSO and Partner, Third Rock Ventures

    2015 - 2015

  • Interim CSO and Partner, Third Rock Ventures

    2015 - 2015

  • Interim CSO and Partner, Third Rock Ventures

    2015 - 2015

Neon

  • Interim CSO and Partner, Third Rock Ventures

    2015 - 2015

  • Interim CSO and Partner, Third Rock Ventures

    2015 - 2015

MP

Millennium Pharmaceuticals

  • President, Research & Development

    1994 - 2007

MGH Cancer Center

  • PI

    1990 - 1994

Education 

Investments 

Casma Therapeutics

Series C

Total funding: $160M

Constellation Pharmaceuticals

Series A

Total funding: $390M

Allena Pharmaceuticals

Series A

Total funding: $93M

Kala Pharmaceuticals

Private Equity

Total funding: $110M

Articles About Robert

Relevant Websites